Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05836688 · ClinicalTrials.gov registry record · NA
A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors
A NA study of Testicular Cancer, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05836688: Recruiting NA study of Testicular Cancer, sponsored by University of California, Irvine.
NCT05836688 is a NA study of Testicular Cancer that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 250 participants, above the 72-participant average among 11 other Testicular Cancer trials with a reported enrollment target (247% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05836688, a NA study of Testicular Cancer, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Listening (ISL) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1), twelve weeks after intervention (T2) and 24 weeks after the intervention (T3). Additionally, identified biomarkers will be measured at baseline and at T1, T2, and T3.
Primary Outcome
The HADS was developed to assess anxiety and depression in medical patients. It purposefully excluded somatic symptoms (e.g., sleep disturbance) to reduce confounding psychological symptoms with disease or treatment. The HADS has become a "benchmark" measure of anxiety and depression among diverse clinical and nonclinical hospital populations, including individuals diagnosed with cancer. The HADS is a 14-item self-administered questionnaire, with 7 items assigned to each the HADS-Anxiety and HAD
Conditions Studied
Interventions
- BEHAVIORAL Goal-Focused Emotion-Regulation Therapy (GET)
- BEHAVIORAL Individual Supportive Listening
Study Locations (1)
California
- University of California, Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT05836688 shows while recruiting
NCT05836688 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 11 other Testicular Cancer trials with a reported enrollment target (247% higher).
The record links to 1 condition, with Testicular Cancer appearing as the primary indexed condition, and to 2 interventions - of which Goal-Focused Emotion-Regulation Therapy (GET) is the first listed.
NCT05836688 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05836688 about?
NCT05836688 is a clinical study titled "A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors". This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive b...
What is the current status of trial NCT05836688?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-11-01. Estimated completion is 2028-07.
What conditions does trial NCT05836688 study?
This clinical trial studies the following conditions: Testicular Cancer.
What interventions are being tested in trial NCT05836688?
The interventions under investigation include: Goal-Focused Emotion-Regulation Therapy (GET) (BEHAVIORAL), Individual Supportive Listening (BEHAVIORAL).
Who is sponsoring clinical trial NCT05836688?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05836688 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Testicular Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05836688's enrollment target sits among peer trials
250 2nd of 11 the highest of 11 other Testicular Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Testicular Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
RECRUITING · NA
-
Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer
ACTIVE NOT RECRUITING · NA
-
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RECRUITING · Phase 1
-
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI